VANESSA ZAMBO: Open Payments
NPI 1881266674 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 81 payments from 15 companies in 2025. Trend: 2023 $1,058 · 2024 $2,072 · 2025 $1,592
Food & beverage: $1,508Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $399 |
| Janssen Biotech, Inc. | 14 | $348 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $163 |
| Ardelyx, Inc. | 6 | $117 |
| Regeneron Healthcare Solutions, Inc. | 5 | $110 |
| Phathom Pharmaceuticals, Inc. | 10 | $110 |
| Madrigal Pharmaceuticals | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| GENZYME CORPORATION | 2 | $52 |
| PFIZER INC. | 3 | $47 |
Products named: TREMFYA, XIFAXAN, DUPIXENT, RINVOQ, SKYRIZI, IBSRELA, VOQUEZNA, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
